These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23972937)

  • 21. Ezetimibe plus simvastatin cardiovascular outcomes study program.
    Padial LR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM; Bang CN; Berg RM; Egstrup K; Rossebø AB; Boman K; Nienaber CA; Ray S; Gohlke-Baerwolf C; Nielsen OW; Okin PM; Devereux RB; Køber L; Wachtell K
    Int J Cardiol; 2015 Feb; 180():122-8. PubMed ID: 25438232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global burden of aortic stenosis.
    Thaden JJ; Nkomo VT; Enriquez-Sarano M
    Prog Cardiovasc Dis; 2014; 56(6):565-71. PubMed ID: 24838132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcific aortic stenosis--time to look more closely at the valve.
    Otto CM
    N Engl J Med; 2008 Sep; 359(13):1395-8. PubMed ID: 18815402
    [No Abstract]   [Full Text] [Related]  

  • 25. Identifying and addressing safety signals in clinical trials.
    Fleming TR
    N Engl J Med; 2008 Sep; 359(13):1400-2. PubMed ID: 18768938
    [No Abstract]   [Full Text] [Related]  

  • 26. Ezetimibe revisited.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
    [No Abstract]   [Full Text] [Related]  

  • 27. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
    Rieck AE; Gerdts E; Lønnebakken MT; Bahlmann E; Cioffi G; Gohlke-Bärwolf C; Ray S; Cramariuc D
    Cardiovasc Ultrasound; 2012 Nov; 10():43. PubMed ID: 23126645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcific aortic valve disease: new concepts.
    Otto CM
    Semin Thorac Cardiovasc Surg; 2010; 22(4):276-84. PubMed ID: 21549267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial].
    Scardi S; Cherubini A
    Ital Heart J Suppl; 2005 Jul; 6(7):403-12. PubMed ID: 16082823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy to prevent progression of calcific aortic stenosis.
    Rajamannan NM; Otto CM
    Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
    Antonini-Canterin F; Hîrşu M; Popescu BA; Leiballi E; Piazza R; Pavan D; Ginghină C; Nicolosi GL
    Am J Cardiol; 2008 Sep; 102(6):738-42. PubMed ID: 18773999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-lowering therapy in calcific aortic stenosis.
    Chan KL; Teo K
    N Engl J Med; 2005 Sep; 353(10):1066-7; author reply 1066-7. PubMed ID: 16148295
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment with statins and angiotensin-converting enzyme inhibitors in degenerative aortic stenosis--an up-date].
    Moldovanu CM; Pandele GI; Ambăruş V; Ionescu S
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):964-74. PubMed ID: 20191861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic stenosis: look globally, think globally.
    Pibarot P; Dumesnil JG
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):400-3. PubMed ID: 19580720
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenesis of calcific aortic valve stenosis].
    Kaden JJ
    Herz; 2006 Oct; 31(7):620-8. PubMed ID: 17072774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis.
    Yamamoto K; Yamamoto H; Yoshida K; Kisanuki A; Hirano Y; Ohte N; Akasaka T; Takeuchi M; Nakatani S; Ohtani T; Sozu T; Masuyama T
    Hypertens Res; 2010 Mar; 33(3):269-74. PubMed ID: 20057483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcific aortic stenosis: same old story?
    Cowell SJ; Newby DE; Boon NA; Elder AT
    Age Ageing; 2004 Nov; 33(6):538-44. PubMed ID: 15308457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis.
    Loomba RS; Arora R
    Am J Ther; 2010; 17(4):e110-4. PubMed ID: 19417587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.